Lista de obras -

Alternative antibody for the detection of CA125 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access OV Monitor assay on the UniCel Dxl 800 Immunoassay System

scientific article published on 01 January 2008

Alternative antibody for the detection of CA15-3 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access BR Monitor assay on the UniCel Dxl 800 Immunoassay System

scientific article published on 01 January 2008

Alternative antibody for the detection of CA19-9 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access GI Monitor assay on the UniCel Dxl 800 Immunoassay System

scientific article published on 01 January 2008

An evaluation of the SENTiFIT 270 analyser for quantitation of faecal haemoglobin in the investigation of patients with suspected colorectal cancer.

artículo científico publicado en 2017

Assessment of a Combined Panel of Six Serum Tumor Markers for Lung Cancer.

artículo científico publicado en 2015

Association between socioeconomic deprivation and colorectal cancer screening outcomes: Low uptake rates among the most and least deprived people.

artículo científico publicado en 2017

CA 19–9 in pancreatic cancer: retrospective evaluation of patients with suspicion of pancreatic cancer

Changes in FIT values below the threshold of positivity and short-term risk of advanced colorectal neoplasia: Results from a population-based cancer screening program

artículo científico publicado en 2018

Circulating levels of HER-2/neu oncoprotein in breast cancer

artículo científico

Clinical applicability of diagnostic biomarkers in early-onset cognitive impairment

scientific article published on 28 March 2019

Clinical utility of %p2PSA and prostate health index in the detection of prostate cancer

artículo científico publicado en 2014

Clinical utility of one versus two faecal immunochemical test samples in the detection of advanced colorectal neoplasia in symptomatic patients.

artículo científico publicado en 2015

Colorectal Cancer Early Screening Program of Barcelona, Spain: Indicators of the first round of a program with participation of community pharmacies

artículo científico publicado en 2014

Colorectal cancer after negative colonoscopy in fecal immunochemical test-positive participants from a colorectal cancer screening program

scholarly article by Liseth Rivero-Sánchez et al published September 2018 in Endoscopy international open

Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases

artículo científico publicado en 2011

Contribution of CSF biomarkers to early-onset Alzheimer's disease and frontotemporal dementia neuroimaging signatures

artículo científico publicado en 2020

Diagnostic relevance of circulating biomarkers in patients with lung cancer

artículo científico publicado en 2010

Evaluation of tumor markers (HER-2/neu oncoprotein, CEA, and CA 15.3) in patients with locoregional breast cancer: prognostic value

artículo científico publicado en 2010

Faecal haemoglobin concentrations do vary across geography as well as with age and sex: ramifications for colorectal cancer screening

artículo científico publicado en 2015

HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases

artículo científico publicado en 2011

Impact of a Primary Care intervention on the colorectal cancer early detection programme

artículo científico publicado en 2019

Impact of age- and gender-specific cut-off values for the fecal immunochemical test for hemoglobin in colorectal cancer screening

artículo científico publicado en 2016

Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as tumor markers in patients with lung cancer: comparison with CYFRA 21-1, CEA, SCC and NSE

scientific article published on 08 December 2008

PCA3 in the detection and management of early prostate cancer

artículo científico publicado en 2013

Phase I trial of gefitinib with concurrent radiotherapy and fixed 2-h gemcitabine infusion, in locally advanced pancreatic cancer

scientific article published on 11 September 2006

Pro-gastrin-releasing peptide in patients with benign and malignant diseases

artículo científico publicado en 2004

ProGRP: a new biomarker for small cell lung cancer

artículo científico publicado en 2004

Prognostic Implications of Protein S-100β Serum Levels in the Clinical Outcome of High-Risk Melanoma Patients

scientific article published on 26 October 2007

Prospective evaluation of carcinoembryonic antigen (CEA) and carbohydrate antigen 15.3 (CA 15.3) in patients with primary locoregional breast cancer.

artículo científico publicado en 2010

Reassessment colonoscopy to diagnose serrated polyposis syndrome in a colorectal cancer screening population.

artículo científico publicado en 2016

Risk stratification for advanced colorectal neoplasia according to fecal hemoglobin concentration in a colorectal cancer screening program.

artículo científico publicado en 2014

Serum 25-hydroxyvitamin D3 levels and vitamin D receptor variants in melanoma patients from the Mediterranean area of Barcelona.

artículo científico publicado en 2013

Serum IGF-I, IGFBP-3, and matrix metalloproteinase-7 levels and acquired chemo-resistance in advanced colorectal cancer

artículo científico publicado en 2008

Serum matrilysin levels predict outcome in curatively resected colorectal cancer patients

artículo científico publicado en 2009

Serum matrix metalloproteinase 7 levels identifies poor prognosis advanced colorectal cancer patients

scientific article published on 01 September 2007

Serum protein s-100 predicts clinical outcome in patients with melanoma treated with adjuvant interferon--comparison with tyrosinase rt-PCR.

artículo científico publicado en 2005

Serum vascular endothelial growth factor as a predictive factor in metronomic (weekly) Paclitaxel treatment for advanced head and neck cancer

artículo científico publicado en 2007

The influence of prostate volume in prostate health index performance in patients with total PSA lower than 10 μg/L

artículo científico publicado en 2014

The role of MMP7 and its cross-talk with the FAS/FASL system during the acquisition of chemoresistance to oxaliplatin

artículo científico publicado en 2009

Tumor Markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in Patients with Non-Small Cell Lung Cancer as an Aid in Histological Diagnosis and Prognosis

Usefulness of serum tumor markers, including progastrin-releasing peptide, in patients with lung cancer: correlation with histology

artículo científico publicado en 2009

Utility of proGRP as a tumor marker in the medullary thyroid carcinoma

artículo científico publicado en 2016

Utility of serum tumor markers as an aid in the differential diagnosis of patients with clinical suspicion of cancer and in patients with cancer of unknown primary site

artículo científico publicado en 2011

Variability of assay methods for total and free PSA after WHO standardization

artículo científico publicado en 2013

Lista de obras de

Alternative antibody for the detection of CA125 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access OV Monitor assay on the UniCel Dxl 800 Immunoassay System

Alternative antibody for the detection of CA15-3 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access BR Monitor assay on the UniCel Dxl 800 Immunoassay System

Alternative antibody for the detection of CA19-9 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access GI Monitor assay on the UniCel Dxl 800 Immunoassay System

An evaluation of the SENTiFIT 270 analyser for quantitation of faecal haemoglobin in the investigation of patients with suspected colorectal cancer.

Assessment of a Combined Panel of Six Serum Tumor Markers for Lung Cancer.

Association between socioeconomic deprivation and colorectal cancer screening outcomes: Low uptake rates among the most and least deprived people.

CA 19–9 in pancreatic cancer: retrospective evaluation of patients with suspicion of pancreatic cancer

Changes in FIT values below the threshold of positivity and short-term risk of advanced colorectal neoplasia: Results from a population-based cancer screening program

Circulating levels of HER-2/neu oncoprotein in breast cancer

Clinical applicability of diagnostic biomarkers in early-onset cognitive impairment

Clinical utility of %p2PSA and prostate health index in the detection of prostate cancer

Clinical utility of one versus two faecal immunochemical test samples in the detection of advanced colorectal neoplasia in symptomatic patients.

Colorectal Cancer Early Screening Program of Barcelona, Spain: Indicators of the first round of a program with participation of community pharmacies

Colorectal cancer after negative colonoscopy in fecal immunochemical test-positive participants from a colorectal cancer screening program

Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases

Contribution of CSF biomarkers to early-onset Alzheimer's disease and frontotemporal dementia neuroimaging signatures

Diagnostic relevance of circulating biomarkers in patients with lung cancer

Evaluation of tumor markers (HER-2/neu oncoprotein, CEA, and CA 15.3) in patients with locoregional breast cancer: prognostic value

Faecal haemoglobin concentrations do vary across geography as well as with age and sex: ramifications for colorectal cancer screening

HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases

Impact of a Primary Care intervention on the colorectal cancer early detection programme

Impact of age- and gender-specific cut-off values for the fecal immunochemical test for hemoglobin in colorectal cancer screening

Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as tumor markers in patients with lung cancer: comparison with CYFRA 21-1, CEA, SCC and NSE

PCA3 in the detection and management of early prostate cancer

Phase I trial of gefitinib with concurrent radiotherapy and fixed 2-h gemcitabine infusion, in locally advanced pancreatic cancer

Pro-gastrin-releasing peptide in patients with benign and malignant diseases

ProGRP: a new biomarker for small cell lung cancer

Prognostic Implications of Protein S-100β Serum Levels in the Clinical Outcome of High-Risk Melanoma Patients

Prospective evaluation of carcinoembryonic antigen (CEA) and carbohydrate antigen 15.3 (CA 15.3) in patients with primary locoregional breast cancer.

Reassessment colonoscopy to diagnose serrated polyposis syndrome in a colorectal cancer screening population.

Risk stratification for advanced colorectal neoplasia according to fecal hemoglobin concentration in a colorectal cancer screening program.

Serum 25-hydroxyvitamin D3 levels and vitamin D receptor variants in melanoma patients from the Mediterranean area of Barcelona.

Serum IGF-I, IGFBP-3, and matrix metalloproteinase-7 levels and acquired chemo-resistance in advanced colorectal cancer

Serum matrilysin levels predict outcome in curatively resected colorectal cancer patients

Serum matrix metalloproteinase 7 levels identifies poor prognosis advanced colorectal cancer patients

Serum protein s-100 predicts clinical outcome in patients with melanoma treated with adjuvant interferon--comparison with tyrosinase rt-PCR.

Serum vascular endothelial growth factor as a predictive factor in metronomic (weekly) Paclitaxel treatment for advanced head and neck cancer

The influence of prostate volume in prostate health index performance in patients with total PSA lower than 10 μg/L

The role of MMP7 and its cross-talk with the FAS/FASL system during the acquisition of chemoresistance to oxaliplatin

Tumor Markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in Patients with Non-Small Cell Lung Cancer as an Aid in Histological Diagnosis and Prognosis

Usefulness of serum tumor markers, including progastrin-releasing peptide, in patients with lung cancer: correlation with histology

Utility of proGRP as a tumor marker in the medullary thyroid carcinoma

Utility of serum tumor markers as an aid in the differential diagnosis of patients with clinical suspicion of cancer and in patients with cancer of unknown primary site

Variability of assay methods for total and free PSA after WHO standardization